CA Intermediate · Advanced Accounting · Applicability of Accounting Standards
Kiran Pharma Ltd, a Level II company, has a profit before tax of Rs 40 lakh. It wants to use the relaxation for Level II and Level III companies relating to AS 15 Employee Benefits. Which is correct?
Level II companies must still apply AS 15 but get relaxations: they can measure defined benefit obligations by a simpler reasonable method instead of the Projected Unit Credit Method and give fewer disclosures. They are not fully exempt from the standard.
- ALevel II companies need not apply AS 15 at all
- BLevel II companies may measure short-term and long-term benefits fully but must disclose nothing about defined benefit plans
- CLevel II companies may use a simplified approach: they need not use the Projected Unit Credit Method, but may use a simpler method such as estimating the liability on a reasonable basis, and have reduced disclosuresCorrect
- DLevel II companies must use the Projected Unit Credit Method and full disclosures like Level I
Explanation
AS 15 applies to Level II and III, but with relaxations: simpler measurement of defined benefit obligation without necessarily using the Projected Unit Credit Method, and reduced disclosures. They are not wholly exempt, and they are not required to follow the full Level I approach.
Did you get it right without looking?
One question tells you little. A timed set on Applicability of Accounting Standards shows your real accuracy, how long you take and where you lose marks.
More Applicability of Accounting Standards questions
- Kaveri Textiles Ltd is an unlisted company. It has no securities listed or in the process of listing, is not a bank, financial institution o…
- Meghna Traders Pvt Ltd is an unlisted company that is not a bank or insurer. Its turnover is Rs 40 crore (excluding other income), borrowing…
- Orion Foods Ltd is a Level II company. For a Level II company, which treatment of AS 17 Segment Reporting is correct under the ICAI framewor…
- Rohan Foods Ltd, an unlisted SMC, has been exempted from AS 17 Segment Reporting in its first year, as SMCs may be. In the following year, i…
- Nirmal Pharma Ltd is a Level I-eligible company by turnover. During the year its tax year fiscal data are: it has three reportable business …
- Ravi Pharma Ltd has equity shares listed on a recognised stock exchange. It is not an SMC. Its management says it will skip AS 17 Segment Re…